Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis

Biochemical Pharmacology

Volumn 71, Issue 10, 2006, Pages 1479-1487

  Balestrieri, Ciro ^a   Felice, Francesca ^a   Piacente, Sonia ^b   Pizza, Cosimo ^b   Montoro, Paola ^b   Oleszek, Wieslaw ^c   Visciano, Vincenzo ^a   Balestrieri, Maria Luisa ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c STATE RESEARCH INSTITUTE   (Poland)

Author keywords

Cell motility; Inflammation; Kaposi's sarcoma; PAF; Stilbenic derivatives; VEGF

Indexed keywords

ACETYL COENZYME A; ACYLTRANSFERASE; HERBACEOUS AGENT; PHENOL DERIVATIVE; PROTEIN P42; PROTEIN P44; RESVERATROL; SYNAPTOPHYSIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; YUCCAOL A; YUCCAOL B; YUCCAOL C;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BARK; BIOSYNTHESIS; CATALYSIS; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MEDICINAL PLANT; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; YUCCA SCHIDIGERA;

ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT BARK; PLANT EXTRACTS; PLATELET ACTIVATING FACTOR; SARCOMA, KAPOSI; SPIRO COMPOUNDS; STILBENES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YUCCA;

EID: 33646037352     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.01.021     Document Type: Article

References (31)

1. Lopez-Velez M., Martinez-Martinez F., and Del Valle-Ribes C. The study of phenolic compounds as natural antioxidants in wine. Crit Rev Food Sci Nutr 43 (2003) 233-244
2. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
3. Ignatowicz E., Baer-Dubowska W., and Resveratrol. a natural chemopreventive agent against degenerative diseases. Pol J Pharmacol 53 (2001) 557-569
4. Hao H.D., and He L.R. Mechanisms of cardiovascular protection by resveratrol. J Med Food 7 (2004) 290-298
5. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273 (1998) 21875-21882
6. Szewczuk L.M., Forti L., Stivala L.A., and Penning T.M. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2. J Biol Chem 279 (2004) 22727-22737
7. Shigematsu S., Ishida S., Hara M., Takahashi N., Yoshimatsu H., Sakata T., et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 34 (2003) 810-817
8. Balestrieri M.L. Biosyntesis of PAF by endothelial cells. In: Mario A. (Ed). Biochemistry of lipids in vascular function (2004), Research Signpost, Kerala, India 139-159
9. Del Sorbo L., Arese M., Girando E., Tizzoni M., Biancone L., Bussolino F., et al. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. Eur J Immunol 31 (2001) 376-383
10. Biancone L., Cantaluppi V., Boccellino M., Bussolanti B., Del Sorbo L., Conaldi P.G., et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. Am J Pathol 155 (1999) 1731-1739
11. Bussolino F., Arese M., Montrucchio G., Barra L., Primo L., Benelli R., et al. Platelet-activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 96 (1995) 940-952
12. Balestrieri M.L., Castaldo C., Balestrieri C., Quagliuolo L., Giovane L., and Servillo L. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. J Lipid Res 44 (2003) 380-387
13. Balestrieri M.L., Nicolaus B., Pari P., Schiano Moriello V., Strazzullo G., Iorio E.L., et al. Lycopene in association with alpha-tocopherol or tomato lipophilic extracts enhances the acyl-PAF biosynthesis in endothelial cells during oxidative stress. Free Radic Biol Med 36 (2004) 1058-1067
14. Bae K., Longobardi L., Karasawa K., Malone B., Inoue T., Akoi J., et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. J Biol Chem 275 (2000) 26704-26709
15. Cheeke P.P. Saponins: surprising benefits of desert plants (1998), The Linus Pauling Institute Newsletter, Oregon State University, Corvallis, OR p. 4-5
16. Oleszek W., Sitek M., Stochmal A., Piacente S., Pizza C., and Cheeke P. Resveratrol and other phenolics from the bark of Yucca schidigera roezl. J Agric Food Chem 49 (2001) 747-752
17. Piacente S., Montoro P., Oleszek W., and Pizza C. Yucca schidigera bark: phenolic constituents and antioxidant activity. J Nat Prod 67 (2004) 882-885
18. Olas B., Wachowicz B., Stochmal A., and Oleszek W. Inhibition of blood platelet adhesion and secretion by different phenolics from Yucca schidigera Roezl. bark. Nutrition 21 (2005) 199-206
19. Marzocco S., Piacente S., Pizza C., Oleszek W., Stochmal A., Pinto A., et al. Inhibition of inducible nitric oxide synthase expression by Yuccaol C from Yucca schidigera Roezl. Life Sci 75 (2004) 1491-1501
20. Bernatchez P.N., Soker S., and Sirois M. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet activating factor synthesis is Flk-1-dependent. J Biol Chem 274 (1999) 31047-31054
21. Munshi N., Jerome E., Groopman J.E., Gill P.S., Ramesh K., and Ganju R.K. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. J Immunol 164 (2000) 1169-1174
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
23. Balestrieri M.L., Servillo L., and Lee T.-C. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells. J Biol Chem 272 (1997) 17431-17437
24. Bligh E.G., and Dyer W.T. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 261 (1959) 911-917
25. Marchiò S., Primo L., Pagano M., Palestro G., Albini A., Veikkola T., et al. Vascular endothelial growth factor-c stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem 274 (1999) 27617-27622
26. Gao X., Xu Y.X., Janakiraman N., Chapman R.A., and Gautam S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem Pharmacol 62 (2001) 1299-1308
27. Guo D., Jia Q., Song H.Y., Warren R.S., and Donner D.B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains: association with endothelial cell proliferation. J Biol Chem 270 (1995) 6729-6733
28. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind S.J., et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpes virus is a viral oncogene and angiogenesis activator. Nature 391 (1998) 86-89
29. Brakenhielm E., Cao R.H., and Cao Y.H. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15 (2001) 1798-1800
30. El Mowafy A.M., and White R.E. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett 451 (1999) 63-67
31. Murakami-Mori K., Mori S., Benjamin Bonavida B., and Nakamura S. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-α-induced ERK1/2 activation in Kaposi's Sarcoma cells. J Immunol 162 (1999) 3672-3679